Published in Acta Psychiatr Scand on November 01, 1998
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med (1999) 9.26
Endogenous opioid peptides: multiple agonists and receptors. Nature (1977) 8.21
Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72
Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA (1992) 5.07
Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep (1998) 4.85
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br J Pharmacol (1972) 4.11
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
The use of an optical brightener in the study of plant structure. Stain Technol (1975) 3.70
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res (1975) 3.26
Head and neck schwannomas--a 10 year review. J Laryngol Otol (2000) 3.25
Chronic conditions and risk of in-hospital death. Health Serv Res (1994) 3.00
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89
Why is care in the community perceived as a failure? Br J Psychiatry (2001) 2.88
Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ (1997) 2.87
The 'new cross-cultural psychiatry'. A case of the baby and the bathwater. Br J Psychiatry (1990) 2.64
The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol (1977) 2.59
Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J (1978) 2.41
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther (2015) 2.34
Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol. Clin Radiol (2011) 2.30
Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J (1979) 2.30
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24
Errors in using tobacco withdrawal scale. Tob Control (1998) 2.23
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 2.09
Osteopontin--a molecule for all seasons. QJM (2002) 2.09
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
Public education for community care. A new approach. Br J Psychiatry (1996) 2.04
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
Community attitudes to mental illness. Br J Psychiatry (1996) 2.02
The phototropin family of photoreceptors. Plant Cell (2001) 2.01
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr (2004) 1.97
The TAPS Project. 4: An observational study of the social life of long-stay patients. Br J Psychiatry (1990) 1.94
A prokaryotic phytochrome. Nature (1997) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A (2000) 1.89
Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci (1975) 1.88
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care (2005) 1.87
The measurement of expressed emotion in the families of psychiatric patients. Br J Soc Clin Psychol (1976) 1.85
Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis (1979) 1.85
Value of routine chest radiography of psychiatric patients. Br Med J (1980) 1.84
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol (1997) 1.82
Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol (1998) 1.79
Community knowledge of mental illness and reaction to mentally ill people. Br J Psychiatry (1996) 1.78
A controlled trial of social intervention in the families of schizophrenic patients. Br J Psychiatry (1982) 1.74
Incorporation of labelled amino acids into the enkephalins. FEBS Lett (1977) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
First-contact incidence rates of schizophrenia in Trinidad and one-year follow-up. Br J Psychiatry (1996) 1.71
Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci (1975) 1.71
Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study. Br J Psychiatry (2005) 1.70
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatr Pulmonol (2003) 1.61
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Characterization of recombinant phytochrome from the cyanobacterium Synechocystis. Proc Natl Acad Sci U S A (1997) 1.60
Intensive care-management at home: an alternative to institutional care? Age Ageing (2001) 1.58
Lead exposure in a firing range. Am J Public Health (1987) 1.58
In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol (1977) 1.56
Inhibition of noradrenaline release by lysergic acid diethylamide. Br J Pharmacol (1973) 1.56
A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technol Assess (2006) 1.53
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet Rec (2013) 1.51
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med (2001) 1.50
The TAPS Project 41: homes for life? Residential stability five years after hospital discharge. Team for the Assessment of Psychiatric Services. Community Ment Health J (1998) 1.50
The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder. Psychol Med (2010) 1.49
SnR30: a new, essential small nuclear RNA from Saccharomyces cerevisiae. Nucleic Acids Res (1988) 1.48
Incidence and outcome of schizophrenia in whites, African-Caribbeans and Asians in London. Psychol Med (1997) 1.48
Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr (1995) 1.47
Corneal astigmatism in preschool Native Americans. J Am Optom Assoc (1997) 1.46
The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend (1995) 1.46
Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet (1997) 1.45
The chemical stain removal properties of 'whitening' toothpaste products: studies in vitro. Br Dent J (2000) 1.43
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med (2007) 1.43
The uptake and disposition of dl-norepinephrine in perfused rat lung. J Pharmacol Exp Ther (1969) 1.40
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int (2001) 1.40
The first contact of patients with schizophrenia with psychiatric services: social factors and pathways to care in a multi-ethnic population. Psychol Med (1999) 1.40
Bridging the chasm: incorporating the medically compromised patient into psychiatric practice. J Psychosoc Nurs Ment Health Serv (1997) 1.39
Midazolam infusion in a pediatric intensive care unit. Ann Pharmacother (1993) 1.38
Evaluating the transfer of care from psychiatric hospitals to district-based services. Br J Psychiatry Suppl (1993) 1.38
Phytochrome Cph1 from the cyanobacterium Synechocystis PCC6803. Purification, assembly, and quaternary structure. Eur J Biochem (2001) 1.36
Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr (2004) 1.36
Evaluation of neuronal and extraneuronal uptake mechanisms during adrenergic nerve stimulation. Br J Pharmacol (1971) 1.34
Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study. Psychol Med (2008) 1.32
The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med (1998) 1.32
A method for screening the quality of hospital care using administrative data: preliminary validation results. QRB Qual Rev Bull (1992) 1.32